The Science Behind Sight Guard: Research Supported Ingredients for Eye Health and Vision Support

As an ophthalmologist, I spend a lot of time with patients who want to do more for their eyes between appointments. They are taking their drops, keeping their follow-ups, and doing everything right. And they want to know: is there anything else I can do?

That question is what led me to formulate Sight Guard. I wanted a supplement I could actually stand behind, built from ingredients with real science behind them, at doses that make sense for daily long-term use. This article walks through each ingredient, what the research shows, and why I chose to include it.

This article is for educational purposes only and is not medical advice. Always speak with your eye care provider about what is right for your specific situation.

What Is Sight Guard?

Sight Guard is a daily eye health supplement I formulated to support the cellular systems that healthy eyes depend on: energy production, antioxidant defense, and retinal cell resilience. The five ingredients I selected each address a different piece of that picture, and together they cover the areas I find most compelling in the current research.

• Nicotinamide riboside (NR) 300 mg
• Calcium pyruvate 400 mg
• Coenzyme Q10 (CoQ10) 100 mg
• Ginkgo biloba extract 60 mg
• Lutein 10 mg

Sight Guard is designed to work alongside your prescribed care, not instead of it. Think of it as giving your eyes the best possible daily nutritional foundation.

The Science Behind Each Ingredient

Lutein: The Gold Standard for Retinal Nutrition

If there is one eye health nutrient that has earned its place in the research literature, it is lutein. Your macula naturally concentrates lutein from the foods you eat, using it to filter high-energy blue light and neutralize the oxidative stress that builds up in retinal tissue every day. The problem is that most people do not eat nearly enough lutein-rich foods to keep those levels optimal, and they decline with age.

The evidence for lutein supplementation comes from one of the most rigorous nutritional trials ever conducted in ophthalmology.

AREDS2 Research Group. JAMA. 2013. doi:10.1001/jama.2013.4997
This large, long-term randomized controlled trial found that daily supplementation with lutein (10 mg) and zeaxanthin (2 mg) supported macular health and reduced the risk of progression in people with age-related macular degeneration. Lutein and zeaxanthin outperformed beta-carotene in the formulation.

Sight Guard contains exactly 10 mg of lutein, matching the AREDS2 dose. For anyone serious about long-term macular health, this is the dose the science points to.

Nicotinamide Riboside (NR): Fueling the Cells That Power Your Vision

Your retinal ganglion cells, the neurons that carry visual signals from your eye to your brain, have among the highest energy demands of any cell in the body. They run on NAD+, a molecule that is absolutely central to cellular energy production and repair. The challenge: NAD+ levels decline steadily with age, and that decline has been linked in research to increased vulnerability in retinal tissue.

NR is one of the most efficient ways to raise NAD+ levels. It enters the NAD+ production pathway more directly than older forms of vitamin B3, and it does so without the side effects associated with high-dose nicotinamide.

The animal research on NR and retinal ganglion cells is genuinely exciting. Two studies from the Emory University ophthalmology research group found that systemic NR supplementation protected retinal ganglion cells and preserved retinal function in mouse models of glaucoma. Zhang et al. (2021, Pharmaceutics; doi:10.3390/pharmaceutics13060893) showed protection in both acute and chronic RGC damage models. A 2024 study from the same group found that oral NR robustly increased retinal NAD+ levels and significantly protected against RGC loss and optic nerve atrophy in an inherited glaucoma model.

Human research on NAD+ support in glaucoma is also advancing. The De Moraes et al. phase 2 trial at Columbia University (published in JAMA Ophthalmology, 2022; doi:10.1001/jamaophthalmol.2021.4576) found that NAD+ precursor supplementation combined with pyruvate produced significant short-term improvement in visual field function in glaucoma patients. That trial used high-dose nicotinamide rather than NR, and the authors called for longer-term studies to establish the full picture.

An ongoing clinical trial (Leung et al., Trials, 2022; doi:10.1186/s13063-021-05968-1) is now evaluating NR specifically in glaucoma patients at 300 mg daily, the same dose in Sight Guard. The science is moving in a compelling direction, and I am confident that NR belongs in a serious eye health formula.

Calcium Pyruvate: Supporting the Energy Cycle

Pyruvate sits at the heart of how your cells produce energy. It is the end product of glucose metabolism and the entry point into the mitochondrial energy cycle, where it helps generate the ATP that keeps retinal cells functioning under constant demand. It also plays a role in maintaining NAD+/NADH balance, which makes it a natural partner for NR.

The De Moraes clinical trial referenced above used both nicotinamide and pyruvate together, and the combination produced meaningful improvements in visual field function. The researchers noted that the complementary roles of these two molecules in cellular energy metabolism may be part of why the combination worked well.

Sight Guard includes 400 mg of calcium pyruvate as a daily dose formulated for sustained cellular energy support. Pyruvate at this level has an excellent safety profile and works synergistically with NR to support the full NAD+ and mitochondrial energy pathway.

Coenzyme Q10: The Mitochondria's Most Important Antioxidant

CoQ10 has two jobs in your cells, and both matter for eye health. First, it is a critical component of the mitochondrial electron transport chain, the process that generates the majority of cellular energy. Second, it is one of the most potent fat-soluble antioxidants your body produces, protecting mitochondrial membranes from the oxidative damage that accumulates over time. Like NAD+, CoQ10 levels decline with age.

The retinal research on CoQ10 is encouraging. Lee et al. (2014, Investigative Ophthalmology and Visual Science; doi:10.1167/iovs.13-12564) found that dietary CoQ10 promoted retinal ganglion cell survival by approximately 29% and preserved optic nerve axons in a glaucoma mouse model, in addition to blocking key oxidative stress pathways. Ju et al. (2018, Biochemical and Biophysical Research Communications; doi:10.1016/j.bbrc.2018.08.016) found that ubiquinol, the active form of CoQ10, enhanced retinal ganglion cell survival and blocked apoptotic pathways in a model of elevated IOP-induced retinal injury.

CoQ10 is one of those ingredients that I think of as a foundational daily nutrient for anyone focused on mitochondrial health. At 100 mg, Sight Guard delivers a meaningful daily dose alongside the other energy-support ingredients in the formula.

Ginkgo Biloba: Supporting Blood Flow to the Optic Nerve

One of the things I find most interesting about optic nerve health is that pressure is not the whole story. Blood flow to the optic nerve matters too, and it is an area where patients and clinicians often have fewer options. That is where ginkgo biloba comes in.

Ginkgo has been studied for its ability to support ocular blood flow through vasodilation and its platelet-activating factor inhibition, as well as for its antioxidant activity in vascular tissue. The most relevant human trial focused specifically on normal-tension glaucoma, where vascular factors are thought to play an especially important role.

Quaranta L et al. Ophthalmology. 2003;110(2):359-362. doi:10.1016/S0161-6420(02)01745-1
This prospective, randomized, double-masked, placebo-controlled crossover trial in 27 patients with normal-tension glaucoma found significant improvement in visual field indices after ginkgo treatment compared to placebo, with no meaningful changes in IOP, blood pressure, or heart rate.

Sight Guard contains 60 mg of ginkgo biloba extract daily. If you take blood thinners or anticoagulant medications, discuss ginkgo with your physician before starting, as it has mild anticoagulant properties.

Why This Formula Works Together

What I like about this combination is that each ingredient targets a different mechanism, and they are genuinely complementary.

• Energy production: NR and calcium pyruvate work together to support healthy NAD+ levels and fuel the mitochondrial energy cycle that retinal cells depend on every day.
• Antioxidant defense: Lutein, CoQ10, and ginkgo each contribute antioxidant protection through different pathways, covering the range of oxidative stress that retinal tissue faces.
• Blood flow support: Ginkgo adds a vascular dimension that the other ingredients do not directly address, which I think is an underappreciated part of long-term optic nerve health.

This is not a random collection of eye health buzzwords. It is a formula built around the mechanisms I find most compelling and most supported by the research I follow closely as a practicing ophthalmologist.

My Recommendation

If a patient asks me whether they should be taking a daily eye supplement, my answer is that the right formula, with the right ingredients at the right doses, is worth doing. That is why I built Sight Guard. Every ingredient is there for a reason, every dose is deliberate, and the goal is a supplement I would feel good recommending to my own patients.

It works best as part of a complete routine: regular monitoring with your eye doctor, consistency with any prescribed treatments, and the kind of daily cellular support that Sight Guard is designed to provide.

Learn more about Sight Guard and start your daily routine here.

References

1. AREDS2 Research Group. Lutein and zeaxanthin and omega-3 fatty acids for age-related macular degeneration. JAMA. 2013;309(19):2005-2015. doi:10.1001/jama.2013.4997
2. Zhang X, Zhang N, Chrenek MA, et al. Systemic treatment with nicotinamide riboside is protective in two mouse models of retinal ganglion cell damage. Pharmaceutics. 2021;13(6):893. doi:10.3390/pharmaceutics13060893
3. Zhang N, Li Y, Zhang X, et al. Oral supplementation with nicotinamide riboside treatment protects RGCs in DBA/2J mouse model. bioRxiv [Preprint]. 2024. doi:10.1101/2024.12.03.626460
4. De Moraes CG, John SWM, Williams PA, et al. Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmology. 2022;140(1):11-18. doi:10.1001/jamaophthalmol.2021.4576
5. Leung et al. Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol. Trials. 2022. doi:10.1186/s13063-021-05968-1
6. Lee D, Shim MS, Kim KY, et al. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Investigative Ophthalmology and Visual Science. 2014;55(2):993-1005. doi:10.1167/iovs.13-12564
7. Ju WK, Shim MS, Kim KY, et al. Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration. Biochemical and Biophysical Research Communications. 2018;503(4):2639-2645. doi:10.1016/j.bbrc.2018.08.016
8. Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110(2):359-362. doi:10.1016/S0161-6420(02)01745-1

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Sight Guard is a dietary supplement. Consult your physician before starting any supplement regimen.